Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has launched a new Scientific Advisory Board (SAB) consisting of four distinguished clinicians and scientists.
/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its.
KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has launched a new Scientific Advisory Board (SAB) consisting of four distinguished clinicians and scientists.